You are here:
Company

AGILeBiotics

Back to overview

AGILeBiotics B.V. is a pharmaceutical company focusing on the development of novel antibiotics for the treatment of multi-drug resistant infections.

AGILeBiotics belongs to the fund:

Pharma Connect Capital">

Investment fund Pharma Connect Capital (PCC) invests in very early-stage medicine development, drug delivery and biomarkers from the High Throughput Screening phase up to Phase 1 (sometimes Phase 2) and other projects...

Carduso Capital B.V.">

Carduso Capital participates in technology companies that are preferably based on the know-how represented in and originating from the Groningen science cluster in and around the University of Groningen (RUG) and the ...

View all the funds from the IFG

Berk Partners Groeifonds invests in existing, fast-growing Dutch SME companies, mainly in the following industries: inno...
Investment fund Pharma Connect Capital (PCC) invests in very early-stage medicine development, drug delivery and biomark...